Autophagy regulates transforming growth factor β signaling and receptor trafficking

Charles B Trelford1, Gianni M Di Guglielmo1

  • 1Schulich School of Medicine and Dentistry, Western University, Department of Physiology and Pharmacology, London, Ontario N6A 5B7, Canada.

Insights

Inhibiting autophagy reduces transforming growth factor beta (TGFβ) signaling, decreasing epithelial to mesenchymal transition (EMT) and cell migration in lung cancer. This occurs by regulating TGFβ receptor trafficking and Smad2/Smad3 phosphorylation.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Transforming growth factor beta (TGFβ) signaling promotes tumorigenesis via epithelial to mesenchymal transition (EMT) and cell migration.
  • TGFβ receptor endocytosis and trafficking regulate its signaling.
  • Autophagy, a cellular degradation process, plays a role in cellular signaling pathways.

Purpose of the Study:

  • To investigate the role of autophagy in regulating TGFβ-induced EMT and cell migration.
  • To determine how autophagy inhibition affects TGFβ receptor trafficking and downstream signaling.

Main Methods:

  • Autophagy was inhibited in non-small cell lung cancer cells using chemical inhibitors (chloroquine, spautin-1, ULK-101) and siRNA targeting ATG5 and ATG7.
  • TGFβ1-dependent EMT markers, cell migration, and stress fiber formation were assessed.
  • TGFβ receptor internalization and trafficking were analyzed.
  • Smad2/Smad3 phosphorylation and localization were evaluated using western blotting, subcellular fractionation, and immunofluorescence microscopy.

Main Results:

  • Autophagy inhibition decreased TGFβ1-induced EMT transcription factors, cell marker expression, stress fiber formation, and cell migration.
  • Inhibition of autophagy led to reduced internalization and lysosomal trafficking of TGFβ receptors.
  • Impaired autophagy attenuated Smad2/Smad3 phosphorylation and nuclear accumulation, shortening the signaling duration.

Conclusions:

  • Autophagy regulates TGFβ signaling pathways crucial for EMT and cell migration.
  • Inhibiting autophagy disrupts TGFβ receptor trafficking, thereby attenuating pro-tumorigenic TGFβ signaling.
  • Targeting autophagy may represent a therapeutic strategy to inhibit TGFβ-driven tumor progression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
10.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K